Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2017-04-26 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
华泰联合证券有限责任公司关于公司内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-evaluation report verification opinion issued by Huatai United Securities Co., Ltd., acting as the sponsor institution for Jiashitang Pharmaceutical Co., Ltd. It references the 2016 internal control self-evaluation report and provides detailed assessment criteria for internal control deficiencies, both financial and non-financial. The document includes the sponsor's verification opinion on the internal control report, concluding no major deficiencies and confirming compliance with relevant laws and regulations. The document length is 3272 characters, which is relatively short and primarily consists of an opinion on the internal control self-evaluation report rather than the report itself. This fits the profile of an Audit Report / Information (AR) as it is a standalone audit-related verification and opinion on internal controls, not a full annual report or other types of filings. Therefore, the appropriate classification is AR with high confidence. FY 2016
2017-04-26 Chinese
华泰联合证券有限责任公司关于公司内部控制规则落实情况自查表的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from Huatai United Securities regarding the internal control rules implementation self-assessment form of Jiashitang Pharmaceutical Co., Ltd. It is a formal attestation by the sponsor institution confirming the company's internal control compliance and effectiveness. The document does not contain financial statements or detailed financial data, nor is it an announcement of a report publication. It is primarily a certification or attestation related to internal controls, which aligns with the category of Regulatory Filings (RNS) as per the certification rule.
2017-04-26 Chinese
内部控制规则落实自查表
Audit Report / Information Classification · 90% confidence The document is titled '嘉事堂药业股份有限公司内部控制规则落实自查表' which translates to 'Internal Control Rules Implementation Self-Inspection Form' for the company 嘉事堂药业股份有限公司. The content is a detailed checklist regarding internal control procedures, including internal audit operations, information disclosure controls, insider trading controls, fundraising controls, related party transactions, external guarantees, major investments, and other important matters. It is a self-assessment form related to internal controls rather than a full audit report or annual report. The document length is 3631 characters, which is relatively short and does not contain financial statements or substantive financial data. It is not an announcement of a report but a compliance/internal control checklist. This type of document fits best under Audit Report / Information (AR) as it relates to internal control and audit-related information but is not a full annual report or financial statement. Therefore, the classification is AR with high confidence. FY 2016
2017-04-26 Chinese
关于2016年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is a public announcement from a company regarding its 2016 annual profit distribution plan. It includes details about the profit distribution proposal, board and supervisory committee approvals, independent director opinions, and risk warnings. The document does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). Instead, it focuses on the dividend distribution plan and related approvals, which aligns with a Notice of Dividend Amount (DIV) filing. The document length is short (1717 characters), and it is not merely announcing the publication of a report but providing substantive information about the dividend plan itself. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2017-04-26 Chinese
2016年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2016年度内部控制自我评价报告" which translates to "2016 Annual Internal Control Self-Evaluation Report." It discusses the company's internal control environment, risk assessment, control activities, and evaluation of internal control effectiveness for the fiscal year 2016. The document includes detailed descriptions of internal control systems, governance, audit activities, risk management, and compliance with regulatory standards. It explicitly states the evaluation of internal control effectiveness and the absence of major deficiencies in financial and non-financial internal controls. This type of document is a standalone audit-related report focusing on internal control evaluation rather than a full annual report or financial statement. It aligns with the definition of an Audit Report / Information (AR) as it provides audit-related information on internal controls and their effectiveness without being a full annual report or financial statement. The document length (9465 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2016
2017-04-26 Chinese
独立董事2016年度述职报告（徐永光）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2016 Annual Work Report" and contains detailed descriptions of the independent director's activities, attendance at board and shareholder meetings, issuance of independent opinions on various company matters, and oversight of corporate governance and investor protection during the 2016 fiscal year. It is a narrative report on the director's duties and observations rather than a financial report or announcement. The content focuses on governance and supervisory roles rather than financial results or regulatory filings. Therefore, it fits best under the category of Board/Management Information (MANG), which includes announcements or reports related to board members' activities and management information.
2017-04-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.